125 related articles for article (PubMed ID: 38154440)
41. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
42. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
[TBL] [Abstract][Full Text] [Related]
43. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts.
Cao S; Durrani FA; Rustum YM
Clin Cancer Res; 2004 Apr; 10(7):2561-9. PubMed ID: 15073137
[TBL] [Abstract][Full Text] [Related]
44. Selenium-Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization.
Qiao R; Yuan Z; Yang M; Tang Z; He L; Chen T
Adv Sci (Weinh); 2024 Jun; ():e2402039. PubMed ID: 38828705
[TBL] [Abstract][Full Text] [Related]
45. Selenium Nanoparticles Synthesized Using
Rajkumar K; Mvs S; Koganti S; Burgula S
Int J Nanomedicine; 2020; 15():4523-4540. PubMed ID: 32606692
[TBL] [Abstract][Full Text] [Related]
46. Biological effects of a nano red elemental selenium.
Zhang JS; Gao XY; Zhang LD; Bao YP
Biofactors; 2001; 15(1):27-38. PubMed ID: 11673642
[TBL] [Abstract][Full Text] [Related]
47. Theranostic applications of selenium nanomedicines against lung cancer.
Liu S; Wei W; Wang J; Chen T
J Nanobiotechnology; 2023 Mar; 21(1):96. PubMed ID: 36935493
[TBL] [Abstract][Full Text] [Related]
48. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro.
Karthikeyan S; Kanimozhi G; Prasad NR; Mahalakshmi R
Toxicol In Vitro; 2011 Oct; 25(7):1366-75. PubMed ID: 21600977
[TBL] [Abstract][Full Text] [Related]
49. (E)-2'-deoxy-2'-(fluoromethylene) cytidine potentiates radioresponse of two human solid tumor xenografts.
Sun LQ; Li YX; Guillou L; Coucke PA
Cancer Res; 1998 Dec; 58(23):5411-7. PubMed ID: 9850073
[TBL] [Abstract][Full Text] [Related]
50. Selenium: a double-edged sword for defense and offence in cancer.
Brozmanová J; Mániková D; Vlčková V; Chovanec M
Arch Toxicol; 2010 Dec; 84(12):919-38. PubMed ID: 20871980
[TBL] [Abstract][Full Text] [Related]
51. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
[TBL] [Abstract][Full Text] [Related]
52. Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase.
He L; Ji S; Lai H; Chen T
J Mater Chem B; 2015 Nov; 3(42):8383-8393. PubMed ID: 32262891
[TBL] [Abstract][Full Text] [Related]
53. Protective Effects of Selenium Nanoparticle-Enriched Lactococcus lactis NZ9000 against Enterotoxigenic Escherichia coli K88-Induced Intestinal Barrier Damage in Mice.
Chen Y; Qiao L; Song X; Ma L; Dou X; Xu C
Appl Environ Microbiol; 2021 Nov; 87(23):e0163621. PubMed ID: 34524898
[TBL] [Abstract][Full Text] [Related]
54. Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment.
van Oorschot B; Granata G; Di Franco S; Ten Cate R; Rodermond HM; Todaro M; Medema JP; Franken NA
Oncotarget; 2016 Oct; 7(40):65504-65513. PubMed ID: 27602767
[TBL] [Abstract][Full Text] [Related]
55. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
56. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells.
Wang Y; Yang L; Zhang J; Zhou M; Shen L; Deng W; Liang L; Hu R; Yang W; Yao Y; Zhang H; Zhang Z
Int J Oncol; 2018 Oct; 53(4):1667-1680. PubMed ID: 30085332
[TBL] [Abstract][Full Text] [Related]
57. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling.
Lai H; Zeng D; Liu C; Zhang Q; Wang X; Chen T
Biomaterials; 2019 Oct; 219():119377. PubMed ID: 31374478
[TBL] [Abstract][Full Text] [Related]
58. Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.
Agoni L; Basu I; Gupta S; Alfieri A; Gambino A; Goldberg GL; Reddy EP; Guha C
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1180-7. PubMed ID: 24529717
[TBL] [Abstract][Full Text] [Related]
59. A comparative study on the accumulation, translocation and transformation of selenite, selenate, and SeNPs in a hydroponic-plant system.
Li Y; Zhu N; Liang X; Zheng L; Zhang C; Li YF; Zhang Z; Gao Y; Zhao J
Ecotoxicol Environ Saf; 2020 Feb; 189():109955. PubMed ID: 31759745
[TBL] [Abstract][Full Text] [Related]
60. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Kamer S; Ren Q; Dicker AP
Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
